Gabelli & Co Investment Advisers’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,250
Closed -$290K 254
2024
Q3
$290K Hold
10,250
0.05% 138
2024
Q2
$196K Buy
10,250
+250
+3% +$6.38K 0.03% 191
2024
Q1
$328K Hold
10,000
0.06% 143
2023
Q4
$330K Hold
10,000
0.06% 142
2023
Q3
$272K Hold
10,000
0.04% 154
2023
Q2
$303K Hold
10,000
0.05% 143
2023
Q1
$325K Buy
10,000
+2,000
+25% +$63.2K 0.06% 116
2022
Q4
$225K Hold
8,000
0.05% 178
2022
Q3
$287K Sell
8,000
-3,000
-27% -$106K 0.04% 262
2022
Q2
$338K Buy
+11,000
New +$321K 0.04% 265
2021
Q1
Sell
-10,000
Closed -$160K 424
2020
Q4
$160K Hold
10,000
0.02% 261
2020
Q3
$124K Sell
10,000
-8,300
-45% -$97.6K 0.02% 201
2020
Q2
$130K Sell
18,300
-400
-2% -$2.68K 0.03% 159
2020
Q1
$102K Buy
18,700
+7,500
+67% +$67K 0.02% 160
2019
Q4
$101K Sell
11,200
-7,500
-40% -$60.9K 0.01% 178
2019
Q3
$134K Buy
18,700
+3,200
+21% +$23K 0.02% 170
2019
Q2
$123K Buy
15,500
+4,300
+38% +$50.9K 0.01% 174
2019
Q1
$141K Buy
+11,200
New +$177K 0.02% 152
2018
Q2
Sell
-11,000
Closed -$157K 164
2018
Q1
$157K Hold
11,000
0.02% 150
2017
Q4
$135K Sell
11,000
-500
-4% -$7.05K 0.02% 155
2017
Q3
$205K Buy
+11,500
New +$237K 0.02% 151

Other funds holding EVH

Gabelli & Co Investment Advisers's EVH Position: Q4 2024 in Review

Gabelli & Co Investment Advisers sold out of Evolent Health (EVH) in Q4 2024, closing a stake of 10,250 shares — an estimated $290K sold.

Gabelli & Co Investment Advisers first reported a position in EVH in Q3 2017 and held it in 21 quarters. The position peaked at $338K in Q2 2022. 240 funds tracked by Wall St. Rank hold EVH as of Q4 2024.

  • Gabelli & Co Investment Advisers reported no remaining Evolent Health position as of Q4 2024 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 10,250 Evolent Health shares in Q4 2024, an estimated $290K.
  • Gabelli & Co Investment Advisers first reported a position in Evolent Health in Q3 2017 and held it in 21 quarters.
  • Gabelli & Co Investment Advisers's Evolent Health position peaked at $338K in Q2 2022.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q4 2024.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2024, filed 13 Feb 2025.